{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:53:41Z","timestamp":1793224421217,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["1QHP28738"],"award-info":[{"award-number":["1QHP28738"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.oooo.2021.08.015","type":"journal-article","created":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T09:40:22Z","timestamp":1630230022000},"page":"662-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Anticholinergic medication: Related dry mouth and effects on the salivary glands"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0021-7088","authenticated-orcid":false,"given":"Szilvia","family":"Arany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota T.","family":"Kopycka-Kedzierawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas V.","family":"Caprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene E.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2021.08.015_bib0001","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40520-015-0359-7","article-title":"Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence","volume":"28","author":"Collamati","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.oooo.2021.08.015_bib0002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/gerona\/62.1.83","article-title":"Serum anticholinergic activity and motor performance in elderly persons","volume":"62","author":"Nebes","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.oooo.2021.08.015_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","article-title":"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review","volume":"15","author":"Salahudeen","year":"2015","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.oooo.2021.08.015_bib0004","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1176\/jnp.3.3.314","article-title":"The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population","volume":"3","author":"Tollefson","year":"1991","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.oooo.2021.08.015_bib0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0022034511420434","article-title":"Translational and clinical applications of salivary diagnostics","volume":"23","author":"Giannobile","year":"2011","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.oooo.2021.08.015_bib0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ger.12304","article-title":"Anticholinergic burden and dry mouth among Finnish, community-dwelling older adults","volume":"35","author":"Tiisanoja","year":"2018","journal-title":"Gerodontology"},{"issue":"42","key":"10.1016\/j.oooo.2021.08.015_bib0007","first-page":"1","article-title":"Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008","author":"Gu","year":"2010","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.oooo.2021.08.015_bib0008","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/jama.2016.14403","article-title":"Trends in dietary supplement use among U.S. adults from 1999-2012","volume":"316","author":"Kantor","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.oooo.2021.08.015_bib0009","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fnins.2019.01309","article-title":"Anticholinergic drugs in geriatric psychopharmacology","volume":"13","author":"Lopez-Alvarez","year":"2019","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.oooo.2021.08.015_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/adj.12284","article-title":"Dry mouth and older people","volume":"60","author":"Thomson","year":"2015","journal-title":"Aust Dent J"},{"key":"10.1016\/j.oooo.2021.08.015_bib0011","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1741-2358.2008.00223.x","article-title":"Major salivary gland output differs between users and non-users of specific medication categories","volume":"25","author":"Wolff","year":"2008","journal-title":"Gerodontology"},{"key":"10.1016\/j.oooo.2021.08.015_bib0012","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/bcp.12839","article-title":"Pharmacological management of anticholinergic delirium\u2014theory, evidence and practice","volume":"81","author":"Dawson","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0013","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","article-title":"Anticholinergic drug exposure and the risk of dementia: a nested case-control study","volume":"179","author":"Coupland","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.oooo.2021.08.015_bib0014","first-page":"62","article-title":"Anticholinergic burden and dry mouth in middle-aged people","volume":"5","author":"Tiisanoja","year":"2020","journal-title":"JDR Clin Trans Res"},{"key":"10.1016\/j.oooo.2021.08.015_bib0015","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.161.13.1629","article-title":"Risk factors for adverse drug events among nursing home residents","volume":"161","author":"Field","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.oooo.2021.08.015_bib0016","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000358781","article-title":"Salivary secretion: mechanism and neural regulation","volume":"24","author":"Proctor","year":"2014","journal-title":"Monogr Oral Sci"},{"key":"10.1016\/j.oooo.2021.08.015_bib0017","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/odi.12402","article-title":"World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction","volume":"22","author":"Villa","year":"2016","journal-title":"Oral Dis"},{"key":"10.1016\/j.oooo.2021.08.015_bib0018","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s40266-018-0588-5","article-title":"Medication-induced xerostomia and hyposalivation in the elderly: culprits, complications, and management","volume":"35","author":"Barbe","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.oooo.2021.08.015_bib0019","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12968\/denu.2016.43.2.186","article-title":"Antimuscarinics in older people: dry mouth and beyond","volume":"43","author":"Bostock","year":"2016","journal-title":"Dent Update"},{"key":"10.1016\/j.oooo.2021.08.015_bib0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1477-7525-4-86","article-title":"The impact of xerostomia on oral-health-related quality of life among younger adults","volume":"4","author":"Thomson","year":"2006","journal-title":"Health Qual Life Outcomes"},{"issue":"1080-1085","key":"10.1016\/j.oooo.2021.08.015_bib0021","first-page":"e1082","article-title":"The effect of xerostomic medication on oral health in persons with dementia","volume":"19","author":"Lexomboon","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.oooo.2021.08.015_bib0022","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.psychres.2016.07.047","article-title":"Antipsychotic medications and dental caries in newly diagnosed schizophrenia: a nationwide cohort study","volume":"245","author":"Hu","year":"2016","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.oooo.2021.08.015_bib0023","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0003-9969(01)00003-6","article-title":"Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ","volume":"46","author":"Bardow","year":"2001","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0024","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1600-0528.2010.00588.x","article-title":"Associations between oral and ocular dryness, labial and whole salivary flow rates, systemic diseases and medications in a sample of older people","volume":"39","author":"Smidt","year":"2011","journal-title":"Community Dent Oral Epidemiol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0025","doi-asserted-by":"crossref","first-page":"k1315","DOI":"10.1136\/bmj.k1315","article-title":"Anticholinergic drugs and risk of dementia: case-control study","volume":"361","author":"Richardson","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.oooo.2021.08.015_bib0026","first-page":"3","article-title":"Muscarinic receptor subtypes in the alimentary tract","volume":"60","author":"Tobin","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0027","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2174\/1570159X14666160607212615","article-title":"Acetylcholinesterase inhibitors and drugs acting on muscarinic receptors\u2014potential crosstalk of cholinergic mechanisms during pharmacological treatment","volume":"15","author":"Soukup","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0028","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1755-5949.2011.00249.x","article-title":"Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets","volume":"18","author":"Scarr","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.oooo.2021.08.015_bib0029","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bjp.0706147","article-title":"Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing","volume":"144","author":"Mansfield","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/mol.66.2.260","article-title":"Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice","volume":"66","author":"Gautam","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0031","doi-asserted-by":"crossref","first-page":"C1963","DOI":"10.1152\/ajpcell.1996.271.6.C1963","article-title":"Both M1 and M3 receptors regulate exocrine secretion by mucous acini","volume":"271","author":"Culp","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0032","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1469-445X.1999.tb00083.x","article-title":"Advances in the pharmacological control of the bladder","volume":"84","author":"Andersson","year":"1999","journal-title":"Exp Physiol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0033","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1124\/jpet.104.067140","article-title":"Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland","volume":"310","author":"Nelson","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.oooo.2021.08.015_bib0034","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jphs.2019.05.001","article-title":"Muscarinic receptor binding of fesoterodine, 5-hydroxymethyl tolterodine, and tolterodine in rat tissues after the oral, intravenous, or intravesical administration","volume":"140","author":"Yamada","year":"2019","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.oooo.2021.08.015_bib0035","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults","volume":"63","author":"Panel","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.oooo.2021.08.015_bib0036","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons","volume":"168","author":"Rudolph","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.oooo.2021.08.015_bib0037","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0091270006292126","article-title":"The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity","volume":"46","author":"Carnahan","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0038","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjmed.2009.02.021","article-title":"Drug burden index score and functional decline in older people","volume":"122","author":"Hilmer","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.oooo.2021.08.015_bib0039","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1365-2125.2012.04411.x","article-title":"Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes","volume":"75","author":"Kersten","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.amjopharm.2006.03.008","article-title":"Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events","volume":"4","author":"Ness","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.oooo.2021.08.015_bib0041","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00784-020-03485-0","article-title":"Anticholinergic burden, oral hygiene practices, and oral hygiene status\u2014cross-sectional findings from the Northern Finland Birth Cohort 1966","volume":"25","author":"Tiisanoja","year":"2021","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.oooo.2021.08.015_bib0042","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","article-title":"Systematic review of anticholinergic risk scales in older adults","volume":"69","author":"Duran","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0043","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1601-0825.2003.03967.x","article-title":"Drug effects on salivary glands: dry mouth","volume":"9","author":"Scully","year":"2003","journal-title":"Oral Dis"},{"key":"10.1016\/j.oooo.2021.08.015_bib0044","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.acthis.2018.02.008","article-title":"Evaluating the effect of three newly approved overactive bladder syndrome treating agents on parotid and submandibular salivary glands: modulation of CXCL10 expression","volume":"120","author":"Aboulhoda","year":"2018","journal-title":"Acta Histochem"},{"key":"10.1016\/j.oooo.2021.08.015_bib0045","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1152\/japplphysiol.00779.2005","article-title":"Distribution and function of muscarinic receptor subtypes in the ovine submandibular gland","volume":"100","author":"Tobin","year":"1985","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0046","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.archoralbio.2008.01.016","article-title":"Cholinergic submandibular effects and muscarinic receptor expression in blood vessels of the rat","volume":"53","author":"Ryberg","year":"2008","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0047","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1067\/moe.2000.105329","volume":"89","author":"Bretz","year":"2000","journal-title":"Minor salivary gland secretion in the elderly. Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2021.08.015_bib0048","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1600-0722.2010.00766.x","article-title":"An update on minor salivary gland secretions","volume":"118","author":"Eliasson","year":"2010","journal-title":"Eur J Oral Sci"},{"key":"10.1016\/j.oooo.2021.08.015_bib0049","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0003-9969(02)00053-5","article-title":"Analysis of residual saliva and minor salivary gland secretions in patients with dry mouth","volume":"47","author":"Lee","year":"2002","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1464-410X.2002.02905.x","article-title":"A randomized controlled trial of tolterodine and oxybutynin on tolerability and clinical efficacy for treating Chinese women with an overactive bladder","volume":"90","author":"Leung","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.oooo.2021.08.015_bib0051","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/15622975.2014.989261","article-title":"Two phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy","volume":"16","author":"Moller","year":"2015","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.oooo.2021.08.015_bib0052","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.pnpbp.2017.12.012","article-title":"Meta-analysis: risk of dry mouth with second generation antidepressants","volume":"84","author":"Cappetta","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.oooo.2021.08.015_bib0053","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0090-4295(00)01113-4","article-title":"Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder","volume":"57","author":"Van Kerrebroeck","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.oooo.2021.08.015_bib0054","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/jgs.15151","article-title":"Medications that cause dry mouth as an adverse effect in older people: a systematic review and metaanalysis","volume":"66","author":"Tan","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.oooo.2021.08.015_bib0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/2042098617725267","article-title":"Assessing and predicting drug-induced anticholinergic risks: an integrated computational approach","volume":"8","author":"Xu","year":"2017","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.oooo.2021.08.015_bib0056","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1532-5415.2002.50123.x","article-title":"Xerostomia and the geriatric patient","volume":"50","author":"Ship","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.oooo.2021.08.015_bib0057","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1741-2358.2001.00021.x","article-title":"Age and medication are significant risk factors for xerostomia in an English population, attending general dental practice","volume":"18","author":"Field","year":"2001","journal-title":"Gerodontology"},{"key":"10.1016\/j.oooo.2021.08.015_bib0058","first-page":"641","volume":"92","author":"Pajukoski","year":"2001","journal-title":"Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2021.08.015_bib0059","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1532-5415.1995.tb05815.x","article-title":"Xerostomia, xerogenic medications and food avoidances in selected geriatric groups","volume":"43","author":"Loesche","year":"1995","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.oooo.2021.08.015_bib0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1741-2358.2007.00213.x","article-title":"Potential factors responsible for dryness of the dorsum of the tongue in elderly requiring care","volume":"25","author":"Ogasawara","year":"2008","journal-title":"Gerodontology"},{"key":"10.1016\/j.oooo.2021.08.015_bib0061","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/ageing\/27.2.123","article-title":"Associations between malnutrition, poor general health and oral dryness in hospitalized elderly patients","volume":"27","author":"Dormenval","year":"1998","journal-title":"Age Ageing"},{"key":"10.1016\/j.oooo.2021.08.015_bib0062","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1177\/00220345000790090301","article-title":"Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress","volume":"79","author":"Bergdahl","year":"2000","journal-title":"J Dent Res"},{"key":"10.1016\/j.oooo.2021.08.015_bib0063","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-160956","article-title":"Anticholinergic exposure and risk of pneumonia in persons with Alzheimer's disease: a nested case-control study","volume":"56","author":"Lampela","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.oooo.2021.08.015_bib0064","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00210-003-0819-z","article-title":"Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms","volume":"369","author":"Ingelman-Sundberg","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/FTD.0b013e31829da990","article-title":"Association between inherited CYP2D6\/2C19 phenotypes and anticholinergic measures in elderly patients using anticholinergic drugs","volume":"36","author":"Kersten","year":"2014","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.oooo.2021.08.015_bib0066","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.14219\/jada.archive.2006.0356","article-title":"Professionally applied topical fluoride: evidence-based clinical recommendations","volume":"137","author":"Affairs","year":"2006","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.oooo.2021.08.015_bib0067","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10266-018-0339-4","article-title":"Clinical oral dryness score: evaluation of a new screening method for oral dryness","volume":"106","author":"Jager","year":"2018","journal-title":"Odontology"},{"key":"10.1016\/j.oooo.2021.08.015_bib0068","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1067\/mpr.2001.113778","article-title":"A review of saliva: normal composition, flow, and function","volume":"85","author":"Humphrey","year":"2001","journal-title":"J Prosthet Dent"},{"key":"10.1016\/j.oooo.2021.08.015_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2017.06.003","article-title":"Medication use and its potential impact on the oral health status of nursing home residents in Flanders (Belgium)","volume":"18","author":"Janssens","year":"2017","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.oooo.2021.08.015_bib0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.oooo.2014.10.027","article-title":"World Workshop on Oral Medicine VI: clinical implications of medication-induced salivary gland dysfunction","volume":"120","author":"Aliko","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0071","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/0976-9668.117000","article-title":"Minor salivary glands and dental caries: approach towards a new horizon","volume":"4","author":"Tandon","year":"2013","journal-title":"J Nat Sci Biol Med"},{"key":"10.1016\/j.oooo.2021.08.015_bib0072","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jphd.12292","article-title":"Caries prevalence and associations with medications and medical comorbidities","volume":"79","author":"Jurasic","year":"2019","journal-title":"J Public Health Dent"},{"key":"10.1016\/j.oooo.2021.08.015_bib0073","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1749-6632.1993.tb18343.x","article-title":"Methods for collecting saliva","volume":"694","author":"Navazesh","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.oooo.2021.08.015_bib0074","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0528.1996.tb00868.x","article-title":"Xerostomia and associated factors in a community-dwelling adult population","volume":"24","author":"Billings","year":"1996","journal-title":"Community Dent Oral Epidemiol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0002-8177(87)54012-0","article-title":"Subjective reports of xerostomia and objective measures of salivary gland performance","volume":"115","author":"Fox","year":"1987","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.oooo.2021.08.015_bib0076","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cden.2014.07.004","article-title":"Oral implications of polypharmacy in the elderly","volume":"58","author":"Singh","year":"2014","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.oooo.2021.08.015_bib0077","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/gerona\/gls176","article-title":"Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial","volume":"68","author":"Kersten","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.oooo.2021.08.015_bib0078","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bcpt.12437","article-title":"Anticholinergic accumulation: a slumbering interaction between drugs and food supplements","volume":"117","author":"Vrolijk","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0079","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.2003.0018","article-title":"Xerostomia: etiology, recognition and treatment","volume":"134","author":"Guggenheimer","year":"2003","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.oooo.2021.08.015_bib0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13195-017-0284-4","article-title":"Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders","volume":"9","author":"Dauphinot","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.oooo.2021.08.015_bib0081","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.archoralbio.2007.07.012","article-title":"Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man","volume":"53","author":"Ryberg","year":"2008","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0082","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","article-title":"Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder","volume":"148","author":"Abrams","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.oooo.2021.08.015_bib0083","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1566-0702(02)00139-X","article-title":"Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats","volume":"100","author":"Tobin","year":"2002","journal-title":"Auton Neurosci"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440321005915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440321005915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:10:04Z","timestamp":1761948604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440321005915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2212440321005915"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2021.08.015","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticholinergic medication: Related dry mouth and effects on the salivary glands","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2021.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}